We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Why Standard Life Aberdeen isn’t the only FTSE 100 7% yielder I’d buy to retire on

Roland Head says Standard Life Aberdeen plc (LON:SLA) could be a contrarian buy for FTSE 100 (INDEXFTSE:UKX) investors.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Shares of Standard Life Aberdeen (LSE: SLA) rose by 3% in early trade this morning, after the asset manager announced plans to return £1.75bn to shareholders following the sale of its life insurance business.

Unfortunately, other figures in today’s half-year results weren’t quite so impressive. Excluding the life insurance business, which is being sold to specialist insurer Phoenix Group, adjusted pre-tax profit was £311m. That’s 12% lower than for the same period last year.

Should you buy aberdeen group shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

The main problem facing the firm is that investors are continuing to withdraw their cash from its funds. Although the group saw £38bn of inflows during the first half, these were outweighed by outflows of £54.6bn. As a result, assets under management and administration fell by £16.6bn to £610.1bn.

This could be a contrarian buy

Asset managers like Standard Life Aberdeen are facing pressure on fees from lower-cost index trackers and algorithmic funds. But cost savings are filtering through from the merger that created it last year.

Costs as a percentage of income fell to 69.4% during the half, compared to 70.6% in 2017. Management’s medium-term target of 60% should help to support profits even if fee income does have further to fall.

A second potential attraction is the £1.75bn capital return that’s being planned. It looks like this will be delivered through share buybacks, which I estimate will reduce the group’s share count by 15%-20%, depending on share price movements.

This should provide a significant boost to future earnings per share. Dividend cover by earnings should also improve, helping to secure the stock’s yield of 7.2%.

Standard Life Aberdeen isn’t out of the woods yet. But at current levels, I think this could be a profitable income buy.

An 8% yielder you shouldn’t ignore

Another stock that’s fallen out of favour over the last year is motor and home insurer Direct Line Insurance Group (LSE: DLG).

The big freeze in the UK at the start of this year caused a surge of claims, hitting profits. Weather-related claims for the six-month period totalled £75m, compared to £9m in 2017.

But it’s worth remembering that this is a normal part of the insurance business and claims losses aside, the half-year performance looked quite good to me.

The group’s return on equity remains attractive, at 15.5%. And the number of policies sold directly under the Direct Line brand rose by 4.1% to 7,018. This helped to offset a fall in sales cause by the end of a deal to sell insurance through the Nationwide Building Society.

Bad weather claims totalled £75m during the period, compared to £9m last year. This meant that half-year operating profit fell by 15.7% to £303.1m. But without the extra claims, operating profit would actually have risen.

The right time to buy?

Long-time chief executive Paul Geddes will leave the firm next summer. Mr Geddes has overseen the group’s growth into a FTSE 100 company and is highly regarded by investors, so his departure is a disappointment.

However, I believe he’ll leave a business that’s in good health. Continued strong cash generation means that despite weather losses, analysts expect Direct Line to declare a special dividend this year in addition to its regular payout.

These payments combined are expected to total 27.8p per share, giving a forecast yield of 8.3%. With it trading on 11 times forecast earnings, I believe this could be a good buying opportunity for long-term income investors.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Standard Life Aberdeen. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

At 8.1%, are investors missing the bigger story behind Legal & General shares?

Andrew Mackie explores Legal & General shares and asks whether investors are still viewing it too narrowly as a yield…

Read more »

Young black female footballer training on stadium pitch
Investing Articles

How has this FTSE 250 share surged ANOTHER 7% today?

Applied Nutrition shares have soared on Monday after another brilliant trading update. So what's the FTSE 250 company's secret?

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

The stock market game you’re actually playing (and why you might be losing)

Our writer recounts a painful experience of making a rash stock market decision based on emotions, not logic – and…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Why is EasyJet stock suddenly a takeover target for US investors?

Andrew Mackie looks at easyjet shares jumping on US takeover talk — but is this a genuine re-rating or just…

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

Have investors got BT shares all wrong?

BT shares spiked during the 1990s telecom boom, then struggled for two decades. Harvey Jones says it's the future that…

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

Looking for buying opportunities in June? Here’s 1 to consider from my Stocks and Shares ISA

The conflict in Iran is making one of the investments in Stephen Wright’s Stocks and Shares ISA volatile. But could…

Read more »

Row of blue European Union flags in Brussels.
Investing Articles

After crashing 13.7% today, is Wise now a stock market bargain at 805p?

Wise was one of the biggest fallers on the UK stock market today. What on earth is going on with…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

At 8% is this eye-popping FTSE 100 dividend yield simply too good to be true?

The dividend yield is to die for, but the share price is lacking in life. Harvey Jones examines whether this…

Read more »